• Explore /
  • Poster
  • / Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using <sup>18</sup>F-BMS-986229 PET.

Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using 18F-BMS-986229 PET.

Abstract Poster

Authors

null

Samuel Louis Cytryn

Memorial Sloan Kettering Cancer Center, New York, NY

Samuel Louis Cytryn , Neeta Pandit-Taskar , Steven Brad Maron , Ping Gu , Geoffrey Yuyat Ku , Joanne F. Chou , Marinela Capanu , Lara Feder , Steven Philemond , Serge K. Lyashchenko , Jason Stuart Lewis , Viktoriya Paroder , Heiko Schöder , Amitabh Srivastava , Laura H. Tang , Yelena Y. Janjigian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT04161781

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 409)

DOI

10.1200/JCO.2024.42.3_suppl.409

Abstract #

409

Poster Bd #

K14

Abstract Disclosures

Similar Posters

First Author: Panpan Zhang

First Author: Antoine Italiano

Poster

2022 ASCO Annual Meeting

Effect of immunotherapy and time-of-day infusion chronomodulation on survival in advanced cancers.

Effect of immunotherapy and time-of-day infusion chronomodulation on survival in advanced cancers.

First Author: Blessie Elizabeth Nelson

First Author: Rutika Mehta